S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase II, Phase ITreatmentActive18 and overNCI, OtherS1211
U10CA032102, nci-2012-01998, SWOG-S1211, NCT01668719

Trial Description

Summary

RATIONALE: Lenalidomide and bortezomib may stop the growth of multiple myeloma by blocking blood flow to the tumor. Also, bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as elotuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy, such as lenalidomide and dexamethasone also work in different ways to kill tumor cells or stop them from growing. Giving elotuzumab together with chemotherapy may be a better way to block cancer growth.

PURPOSE: This phase I/II trial is studying the side effects and best dose of elotuzumab and to see how well it works when given with lenalidomide, bortezomib, and dexamethasone in treating patients with multiple myeloma.

Further Study Information

OBJECTIVES:

  • To determine the appropriate Phase II dose of elotuzumab to use in combination with lenalidomide, bortezomib, and dexamethasone for patients with multiple myeloma. (Phase I)
  • To assess whether incorporation of the novel agent elotuzumab into the treatment algorithm of high-risk multiple myeloma (HRMM) will improve progression-free survival (PFS). (Phase II)
  • To estimate the frequency and severity of toxicities of this treatment strategy in this patient population.

OUTLINE: This is a multicenter, phase I, dose-escalation study of elotuzumab, followed by a phase II, randomized study. Patients are stratified according to primary plasma cell leukemia and/or high lactic dehydrogenase (LDH) vs everyone else.

Phase I:

  • Induction: Patients receive bortezomib subcutaneously (SC) or IV on days 1, 4, 8, and 11; lenalidomide orally (PO) once daily on days 1-14; and dexamethasone PO or IV on days 1, 2, 4, 5, 8, 9, 11, and 12. Patients also receive elotuzumab IV on days 1, 8, and 15 of courses 1 and 2 and on days 1 and 11 of courses 3-8. Treatment repeats every 21 days for 8 courses in the absence of disease progression or unacceptable toxicity.
  • Maintenance: Patients receive bortezomib SC or IV on days 1, 8, and 15; lenalidomide PO once daily on days 1-21; dexamethasone PO on days 1, 8, and 15; and elotuzumab IV on days 1 and 15. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity.

Phase II: Patients are randomized to 1 of 2 treatment arms.

  • Arm I:
  • Induction: Patients receive bortezomib SC or IV on days 1, 4, 8, and 11; lenalidomide PO once daily on days 1-14; and dexamethasone PO or IV on days 1, 2, 4, 5, 8, 9, 11, and 12. Treatment repeats every 21 days for 8 courses in the absence of disease progression or unacceptable toxicity (patients who received a course of chemotherapy prior to registration will begin protocol treatment with course 2 and receive a total of 7 courses of protocol therapy).
  • Maintenance: Patients receive bortezomib SC or IV on days 1, 8, and 15; lenalidomide PO once daily on days 1-21; and dexamethasone PO on days 1, 8, and 15. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity.
  • Arm II:
  • Induction: Patients receive bortezomib, lenalidomide, and dexamethasone as in arm I. Patients also receive elotuzumab IV on days 1, 8, and 15 of courses 1 and 2 and on days 1 and 11 of courses 3-8. Treatment repeats every 21 days for 8 courses in the absence of disease progression or unacceptable toxicity.
  • Maintenance: Patients receive bortezomib, lenalidomide, and dexamethasone as in arm I. Patients also receive elotuzumab IV on days 1 and 15. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity.

After completion of study therapy, patients are followed every 3 months for up to 6 years.

Eligibility Criteria

DISEASE CHARACTERISTICS:

  • Patients must have newly diagnosed active multiple myeloma (MM)
  • Patients with non-secretory MM or known amyloidosis are not eligible
  • For the Phase II portion only, patients must have high-risk MM based on one or more of the following criteria at the time of initial diagnosis (prior to any chemotherapy):
  • Poor-risk genomic signature according to the University of Arkansas 70-gene model (available clinically as MyPRS score, Signal Genetics, Inc.)
  • Translocation (14;16), and/or translocation (14;20), and/or deletion (17p) by florescence in-situ hybridization (FISH) or cytogenetics
  • Primary plasma cell leukemia (defined by either ≥ 2,000 plasma cells/mL of peripheral blood, or 20% on a manual differential count
  • Serum lactate dehydrogenase (LDH) ≥ 2 times institutional upper limit of normal (IULN)
  • Patients must have measurable disease within 28 days prior to registration (or prior to initiation of first induction course for patients with prior therapy)
  • Patients on the Phase I portion may not have received ANY prior chemotherapy
  • Patients on the Phase II portion may have received one prior cycle of any noninvestigational chemotherapy
  • Patients must not have active involvement of the central nervous system (CNS) with MM (by clinical evaluation)
  • Patients with documentation of or clinical signs or symptoms consistent with CNS involvement by MM must have a lumbar puncture that is negative for CNS involvement
  • Patients with no previous history of documented CNS involvement and with no clinical signs or symptoms consistent with CNS involvement are not required to have completed a lumbar puncture prior to registration

PATIENT CHARACTERISTICS:

  • Zubrod performance status ≤ 2
  • Absolute neutrophil count (ANC) ≥ 1,000 cells/mm³ without growth factor support
  • Platelet count ≥ 70,000 cells/mm³ for patients who have bone marrow plasmacytosis < 50% OR ≥ 50,000 cells/mm³ for patients who have bone marrow plasmacytosis of ≥ 50%
  • Total bilirubin ≤ 1.5 times institutional upper limit of normal (IULN)
  • Serum glutamic oxalo-acetic transaminase (SGOT)/aspartate aminotransferase (AST) and serum glutamic pyruvate transaminase (SGPT)/alanine aminotransferase (ALT) ≤ 2.5 times IULN
  • Creatinine clearance (CrCL) ≥ 30 mL/min
  • Patients who are known to be human immunodeficiency virus (HIV)-positive are eligible providing they meet all of the following additional criteria within 28 days prior to registration:
  • CD4 cells ≥ 500/mm³
  • Viral load of < 50 copies HIV mRNA/mm³ if on antiretroviral therapy (ART) or < 25,000 copies HIV mRNA if not on ART
  • No zidovudine or stavudine as part of ART
  • Patients must have baseline skeletal survey to document lytic lesions, osteopenia, or compression fracture
  • Patients with known hepatitis B or hepatitis C infection may be eligible providing they have viral load < 800,000 IU/L within 28 days prior to registration
  • Patients must not have POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
  • Patients must not have clinically significant illness including any of the following:
  • Uncontrolled, active infection requiring intravenous antibiotics
  • New York Heart Association (NYHA) Class III or Class IV heart failure
  • Unstable angina pectoris
  • Myocardial infarction within the past 6 months
  • ≥ Grade 3 cardiac arrhythmias per Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0
  • Patients must have undergone an electrocardiogram (EKG) within 28 days prior to registration
  • Uncontrolled blood pressure (BP) or hypertension
  • Defined as systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg within 14 days prior to registration
  • An exception can be made by a healthcare provider for a patient with a single BP elevation who, upon rechecking, has a normal BP
  • Patients are permitted to be receiving multiple antihypertensive medications (unless otherwise indicated in the study)
  • Uncontrolled diabetes mellitus (defined as a glycosylated hemoglobin A1C (Hg A1C) > 7% within 14 days prior to registration)
  • The same criterion will be used in patients with confirmed diagnosis of diabetes mellitus who have been on a stable dietary or therapeutic regimen for this condition in the last three months
  • Patients must not have any psychiatric illness that could potentially interfere with the completion of treatment according to this protocol
  • Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10-14 days prior to registration
  • FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide and continuing for at least 4 months after completion of study therapy
  • Men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy
  • Not pregnant or breastfeeding
  • No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  • Prior chemotherapy must have been completed within 56 days prior to registration and all toxicities must have resolved to ≤ Grade 1
  • Patients may have received prior radiotherapy for symptomatic localized bone lesions or impending spinal cord compression only
  • Radiotherapy must be completed at least 14 days prior to registration and all toxicities must have resolved to ≤ Grade 1

Trial Contact Information

Trial Lead Organizations/Sponsors

Southwest Oncology Group

  • National Cancer Institute
  • Bristol-Myers Squibb Company - New York
Saad Z. Usmani, Principal Investigator
Cara Laubach
Ph: 2106148808 Ext.1027
Email: claubach@swog.org

Trial Sites

U.S.A.

Alaska
Anchorage

Anchorage Oncology Centre

Alison K Conlin
Ph: 503-215-6412

Katmai Oncology Group

Alison K Conlin
Ph: 503-215-6412

Providence Cancer Center

Alison K Conlin
Ph: 503-215-6412

California
Duarte

City of Hope Comprehensive Cancer Center

Michael A Rosenzweig
Ph: 800-826-4673
Email: becomingapatient@coh.org

Los Angeles

USC/Norris Comprehensive Cancer Center and Hospital

Kevin R Kelly
Ph: 323-865-0451

Kevin R Kelly
Ph: 323-865-0451

Orange

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center

Kanwarpal S Kahlon
Ph: 877-827-8839
Email: ucstudy@uci.edu

Connecticut
Hartford

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

New Britain

George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus

Brian J Byrne
Ph: 860-224-5660

Delaware
Lewes

Tunnell Cancer Center at Beebe Medical Center

Stephen Scott Grubbs
Ph: 302-733-6227

Newark

Christiana Gynecologic Oncology, LLC

Stephen Scott Grubbs
Ph: 302-733-6227

Delaware Clinical and Laboratory Physicians

Stephen Scott Grubbs
Ph: 302-733-6227

Helen F. Graham Cancer Center at Christiana Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Ph: 302-733-6227

Medical Oncology Hematology Consultants, PA at Helen F. Graham Cancer Center

Stephen Scott Grubbs
Ph: 302-733-6227

Regional Hematology/Oncology, PA - Newark

Stephen Scott Grubbs
Ph: 302-733-6227

Rehoboth Beach

Beebe Health Campus

Stephen Scott Grubbs
Ph: 302-733-6227

Seaford

Nanticoke Memorial Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Wilmington

Christiana Care Health System-Wilmington Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Florida
Jacksonville

Mayo Clinic - Jacksonville

Ronald S Go
Ph: 507-538-7623

Hawaii
Aiea

Kapiolani Medical Center at Pali Momi

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Ph: 808-586-2979

Honolulu

Cancer Research Center of Hawaii

Jeffrey L. Berenberg
Ph: 808-586-2979

Kapiolani Medical Center for Women and Children

Jeffrey L. Berenberg
Ph: 808-586-2979

OnCare Hawaii, Incorporated - Kuakini

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Ph: 808-586-2979

OnCare Hawaii, Incorporated - Lusitana

Jeffrey L. Berenberg
Ph: 808-586-2979

Queen's Cancer Institute at Queen's Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Straub Clinic and Hospital, Incorporated

Jeffrey L. Berenberg
Ph: 808-586-2979

Lihue

Kauai Medical Clinic

Jeffrey L. Berenberg
Ph: 808-586-2979

Idaho
Boise

Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Illinois
Bloomington

Illinois CancerCare - Bloomington

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Canton

Illinois CancerCare - Canton

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Carbondale

Memorial Hospital of Carbondale

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Carthage

Illinois CancerCare - Carthage

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Centralia

Centralia Oncology Clinic

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Decatur

Cancer Care Center of Decatur

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Decatur Memorial Hospital Cancer Care Institute

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Effingham

Crossroads Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Eureka

Illinois CancerCare - Eureka

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Galesburg

Galesburg Clinic, PC

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

InterCommunity Cancer Center of Western Illinois

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Harvey

Ingalls Cancer Care Center at Ingalls Memorial Hospital

Mark F. Kozloff
Ph: 708-915-4673
Email: clinicaltrials@ingalls.org

Hines

Veterans Affairs Medical Center - Hines

Nirmala Bhoopalam
Ph: 708-202-8387

Kewanee

Illinois CancerCare - Kewanee Clinic

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Macomb

Illinois CancerCare - Macomb

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Maywood

Cardinal Bernardin Cancer Center at Loyola University Medical Center

Kevin Barton
Ph: 708-226-4357

Moline

Garneau, Stewart C MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Spector, David MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Trinity Cancer Center at Trinity Medical Center - 7th Street Campus

David M Spector
Ph: 309-779-4200

Mount Vernon

Good Samaritan Regional Health Center

Jay W Carlson
Ph: 800-821-7532

Ottawa

Illinois CancerCare - Ottawa

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Radiation Oncology of Northern Illinois

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Pekin

Cancer Treatment Center at Pekin Hospital

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Illinois CancerCare - Pekin

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Peoria

Illinois CancerCare - Peoria

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Methodist Medical Center of Illinois

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Peru

Illinois CancerCare - Princeton

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Valley Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Princeton

Illinois CancerCare - Princeton

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Springfield

Central Illinois Hematology Oncology Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Regional Cancer Center at Memorial Medical Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Simmons Cooper Cancer Institute

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Springfield Clinic - Main Campus

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Indiana
Richmond

Reid Hospital & Health Care Services

Howard M. Gross
Ph: 937-775-1350

Iowa
Ames

McFarland Clinic, PC

Joseph James Merchant
Ph: 515-239-2621

William R. Bliss Cancer Center at Mary Greeley Medical Center

Joseph James Merchant
Ph: 515-239-2621

Bettendorf

Constantinou, Costas L MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Boone

McFarland Clinic PC-Boone

Joseph James Merchant
Ph: 515-239-2621

Fort Dodge

Trinity Regional Medical Center

Joseph James Merchant
Ph: 515-239-2621

Jefferson

McFarland Clinic PC-Jefferson

Joseph James Merchant
Ph: 515-239-2621

Marshalltown

McFarland Clinic PC-Marshalltown

Joseph James Merchant
Ph: 515-239-2621

Sioux City

Siouxland Hematology-Oncology Associates, LLP

Donald Bruce Wender
Ph: 712-252-0088

Kansas
Emporia

Newman Regional Health

Peter J. VanVeldhuizen
Ph: 800-525-1483

Garden City

St. Catherine Hospital Cancer Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Great Bend

St. Rose Ambulatory and Surgery Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Hays

Hays Medical Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Kansas City

Kansas City Cancer Centers - West

Peter J. VanVeldhuizen
Ph: 800-525-1483

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-262-4467

Olathe

Olathe Medical Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Overland Park

Kansas City Cancer Centers - Southwest

Peter J. VanVeldhuizen
Ph: 800-525-1483

Menorah Medical Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Saint Luke's Hospital - South

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Pittsburg

Mount Carmel Regional Cancer Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Salina

Tammy Walker Cancer Center at Salina Regional Health Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Topeka

St. Francis Comprehensive Cancer Center

Peter J. VanVeldhuizen
Ph: 800-525-1483

Wichita

Wesley Medical Center

Shaker R. Dakhil
Ph: 316-262-4467

Kentucky
Crestview Hills

Oncology Hematology Care, Incorporated - Crestview Hills

Howard M. Gross
Ph: 937-775-1350

Louisiana
Baton Rouge

Hematology-Oncology Clinic

Hana F Safah
Ph: 504-988-6121

Marrero

West Jefferson Medical Center

Hana F Safah
Ph: 504-988-6121

New Orleans

Tulane Cancer Center at Tulane University Hospital and Clinic

Hana F Safah
Ph: 504-988-6121

Michigan
Adrian

Hickman Cancer Center at Bixby Medical Center

Rex B Mowat
Ph: 800-444-3561

Ann Arbor

Saint Joseph Mercy Cancer Center

Christopher M Reynolds
Ph: 734-712-4673

Battle Creek

Battle Creek Health System Cancer Care Center

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Dearborn

Oakwood Cancer Center at Oakwood Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Detroit

Barbara Ann Karmanos Cancer Institute

Jeffrey A. Zonder
Email: zonderj@karmanos.org

Van Elslander Cancer Center at St. John Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Wayne State University

Jeffrey A. Zonder
Ph: 313-576-9363

Escanaba

Green Bay Oncology, Limited - Escanaba

Matthew L Ryan
Ph: 800-432-6049

Farmington Hills

Weisberg Cancer Treatment Center

Jeffrey A. Zonder
Ph: 313-576-9363

Flint

Genesys Hurley Cancer Institute

Christopher M Reynolds
Ph: 734-712-4673

Hurley Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Grand Rapids

Butterworth Hospital at Spectrum Health

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Lacks Cancer Center at Saint Mary's Health Care

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Iron Mountain

Green Bay Oncology - Iron Mountain

Matthew L Ryan
Ph: 800-432-6049

Jackson

Gayle M. Jacob Cancer Center at Allegiance Health

Christopher M Reynolds
Ph: 734-712-4673

Kalamazoo

Borgess Medical Center

Sunil Nagpal
Ph: 269-373-7458

Bronson Methodist Hospital

Sunil Nagpal
Ph: 269-373-7458

West Michigan Cancer Center

Sunil Nagpal
Ph: 269-373-7458

Lansing

Sparrow Regional Cancer Center

Christopher M Reynolds
Ph: 734-712-4673

Livonia

St. Mary Mercy Hospital

Christopher M Reynolds
Ph: 734-712-4673

Monroe

Community Cancer Center of Monroe

Rex B Mowat
Ph: 800-444-3561

Muskegon

Mercy General Health Partners

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Niles

Lakeland Hospital - Niles

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Pontiac

St. Joseph Mercy Oakland

Christopher M Reynolds
Ph: 734-712-4673

Port Huron

Mercy Regional Cancer Center at Mercy Hospital

Christopher M Reynolds
Ph: 734-712-4673

Reed City

Spectrum Health Reed City Hospital

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Saginaw

Seton Cancer Institute at Saint Mary's - Saginaw

Christopher M Reynolds
Ph: 734-712-4673

Saint Joseph

Lakeside Cancer Specialists, PLLC

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Southfield

Providence Hospital - Southfield

Andrew A Muskovitz
Ph: 248-849-5337
Email: jaswinder.grewal@stjohn.org

St. Joseph

Lakeland Regional Cancer Care Center - St. Joseph

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Traverse City

Munson Medical Center

Gilbert D Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Warren

St. John Macomb Hospital

Christopher M Reynolds
Ph: 734-712-4673

Minnesota
Bemidji

MeritCare Bemidji

Preston D. Steen
Ph: 701-234-6161

Burnsville

Fairview Ridges Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Coon Rapids

Mercy and Unity Cancer Center at Mercy Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Duluth

CCOP - Duluth

Bret E Friday
Ph: 888-203-7267

Essentia Health - Duluth Clinic

Bret E Friday
Ph: 888-203-7267

Miller - Dwan Medical Center

Bret E Friday
Ph: 888-203-7267

Edina

Fairview Southdale Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Fridley

Mercy and Unity Cancer Center at Unity Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Hutchinson

Hutchinson Area Health Care

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Maplewood

HealthEast Cancer Care at St. John's Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Minnesota Oncology - Maplewood

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Minneapolis

Health Partners Inc

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Hennepin County Medical Center - Minneapolis

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

New Ulm

New Ulm Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Robbinsdale

Humphrey Cancer Center at North Memorial Outpatient Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Rochester

Mayo Clinic Cancer Center

Ronald S Go
Ph: 507-538-7623

Saint Louis Park

Park Nicollet Cancer Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Saint Paul

Regions Hospital Cancer Care Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

United Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Shakopee

St. Francis Cancer Center at St. Francis Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Stillwater

Lakeview Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Waconia

Ridgeview Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Willmar

Willmar Cancer Center at Rice Memorial Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Woodbury

Minnesota Oncology - Woodbury

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Mississippi
Jackson

University of Mississippi Cancer Clinic

Tondre T Buck
Ph: 601-815-6700

Missouri
Bolivar

Central Care Cancer Center at Carrie J. Babb Cancer Center

Jay W Carlson
Ph: 800-821-7532

Bonne Terre

Parkland Health Center-Bonne Terre

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Branson

Skaggs Cancer Center at Skaggs Regional Medical Center

Jay W Carlson
Ph: 800-821-7532

Cape Girardeau

Saint Francis Medical Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Southeast Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Independence

Independence Regional Health Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Jefferson City

Goldschmidt Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Kansas City

Heartland Hematology Oncology Associates, Incorporated

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Kansas City Cancer Centers - North

Peter J. VanVeldhuizen
Ph: 800-525-1483

Kansas City Cancer Centers - South

Peter J. VanVeldhuizen
Ph: 800-525-1483

Research Medical Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Saint Luke's Hospital

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Truman Medical Center - Hospital Hill

Peter J. VanVeldhuizen
Ph: 800-525-1483

Lee's Summit

Kansas City Cancer Centers - East

Peter J. VanVeldhuizen
Ph: 800-525-1483

Saint Luke's East - Lee's Summit

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Liberty

Parvin Radiation Oncology

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rolla

Mercy Clinic Cancer and Hematology - Rolla

Jay W Carlson
Ph: 800-821-7532

Phelps County Regional Medical Center

Jay W Carlson
Ph: 800-821-7532

Saint Joseph

Heartland Regional Medical Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Saint Louis

David C. Pratt Cancer Center at St. John's Mercy

Jay W Carlson
Ph: 800-821-7532

Mercy Clinic St. Louis Cancer and Breast Institute

Jay W Carlson
Ph: 800-821-7532

Missouri Baptist Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Springfield

Hulston Cancer Center at Cox Medical Center South

Jay W Carlson
Ph: 800-821-7532

St. John's Regional Health Center

Jay W Carlson
Ph: 800-821-7532

Sullivan

Missouri Baptist Sullivan Hospital

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Nebraska
Lincoln

Cancer Resource Center - Lincoln

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Nebraska Hematology and Oncology

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Southeast Nebraska Hematology Oncology Consultants at Southeast Nebraska Cancer Center

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Norfolk

Carson Cancer Center at Faith Regional Hospital

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

North Platte

Callahan Cancer Center at Great Plains Regional Medical Center

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Omaha

CCOP - Missouri Valley Cancer Consortium

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Oncology Hematology West PC

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Oncology Hematology West, PC - Omaha Bergan

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Scottsbluff

Cancer Treatment Center at Regional West Medical Center

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Nevada
Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 702-384-0013

Las Vegas Cancer Center - Henderson

John Allan Ellerton
Ph: 702-384-0013

Las Vegas

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 702-384-0013

21st Century Oncology - Vegas Sunrise

John Allan Ellerton
Ph: 702-384-0013

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Fort Apache

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 702-384-0013

Cancer Institute of Nevada at Summerlin Hospital Medical Center

John Allan Ellerton
Ph: 702-384-0013

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 702-384-0013

CCOP - Nevada Cancer Research Foundation

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Southwest

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 702-384-0013

Radiation Oncology Centers of Las Vegas - Downtown Location

John Allan Ellerton
Ph: 702-384-0013

Radiation Oncology Centers of Las Vegas - Eastern Location

John Allan Ellerton
Ph: 702-384-0013

University Medical Center of Southern Nevada

John Allan Ellerton
Ph: 702-384-0013

New York
Rochester

James P. Wilmot Cancer Center at University of Rochester Medical Center

Jonathan W Friedberg
Ph: 585-275-5830

Staten Island

Nalitt Cancer Institute at Staten Island University Hospital

Marcel Odaimi
Ph: 718-226-8888

North Carolina
Charlotte

Blumenthal Cancer Center at Carolinas Medical Center

Saad Z Usmani
Ph: 704-355-2884

Clinton

Southeastern Medical Oncology Center-Clinton

James N. Atkins
Ph: 919-580-0000

Concord

Batte Cancer Center at Northeast Medical Center

Saad Z Usmani
Ph: 704-355-2884

Goldsboro

Southeastern Medical Oncology Center - Goldsboro

James N. Atkins
Ph: 919-580-0000

Wayne Memorial Hospital, Incorporated

James N. Atkins
Ph: 919-580-0000

Jacksonville

Southeastern Medical Oncology Center-Jacksonville

James N. Atkins
Ph: 919-580-0000

Kinston

Kinston Medical Specialists

Peter R. Watson
Ph: 252-559-2200

Monroe

Edwards Cancer Center at Union Regional Medical Center

Saad Z Usmani
Ph: 704-355-2884

Pinehurst

FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center

Charles S Kuzma
Ph: 910-715-2200

Wilson

Southeastern Medical Oncology Center - Wilson

James N. Atkins
Ph: 919-580-0000

North Dakota
Bismarck

Medcenter One Hospital Cancer Care Center

Preston D. Steen
Ph: 701-234-6161

Fargo

Roger Maris Cancer Center at MeritCare Hospital

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Ph: 701-234-6161

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Ohio
Akron

Summa Center for Cancer Care at Akron City Hospital

Jennifer E Payne
Ph: 330-375-6101

Barberton

Barberton Citizens Hospital

Jennifer E Payne
Ph: 330-375-6101

Beachwood

Cleveland Clinic Taussig Cancer Center

Anjali S Advani
Ph: 866-223-8100

Belpre

Strecker Cancer Center-Belpre

J. Philip Kuebler
Ph: 614-566-3275

Centerville

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350

Chillicothe

Adena Regional Medical Center

J. Philip Kuebler
Ph: 614-566-3275

Cincinnati

Oncology Hematology Care Inc - Western Hills

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Anderson

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Blue Ash

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Kenwood

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Mt. Auburn/Taft Road

Howard M. Gross
Ph: 937-775-1350

Cleveland

Case Comprehensive Cancer Center

Brenda W. Cooper
Ph: 800-641-2422

Cleveland Clinic Cancer Center at Fairview Hospital

Anjali S Advani
Ph: 866-223-8100

Cleveland Clinic Taussig Cancer Center

Anjali S Advani
Ph: 866-223-8100

Columbus

Columbus Oncology Associates, Incorporated

J. Philip Kuebler
Ph: 614-566-3275

Doctors Hospital at Ohio Health

J. Philip Kuebler
Ph: 614-566-3275

Grant Medical Center Cancer Care

J. Philip Kuebler
Ph: 614-566-3275

Mount Carmel Health - West Hospital

J. Philip Kuebler
Ph: 614-566-3275

Riverside Methodist Hospital Cancer Care

J. Philip Kuebler
Ph: 614-566-3275

Zangmeister Center

J. Philip Kuebler
Ph: 614-566-3275

Dayton

David L. Rike Cancer Center at Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Good Samaritan Hospital

Howard M. Gross
Ph: 937-775-1350

Samaritan North Cancer Care Center

Howard M. Gross
Ph: 937-775-1350

Delaware

Delaware Health Center

J. Philip Kuebler
Ph: 614-566-3275

Grady Memorial Hospital

J. Philip Kuebler
Ph: 614-566-3275

Fairfield

Oncology Hematology Care, Incorporated - Fairfield Healthplex

Howard M. Gross
Ph: 937-775-1350

Findlay

Blanchard Valley Regional Cancer Center

Howard M. Gross
Ph: 937-775-1350

Franklin

Atrium Medical Center

Howard M. Gross
Ph: 937-775-1350

Greenville

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350

Independence

Cleveland Clinic Taussig Cancer Center

Anjali S Advani
Ph: 866-223-8100

Kettering

Charles F. Kettering Memorial Hospital

Howard M. Gross
Ph: 937-775-1350

Lancaster

Fairfield Medical Center

J. Philip Kuebler
Ph: 614-566-3275

Mansfield

Cleveland Clinic Cancer Center Mansfield

Anjali S Advani
Ph: 866-223-8100

Marietta

Strecker Cancer Center at Marietta Memorial Hospital

J. Philip Kuebler
Ph: 614-566-3275

Maumee

Northwest Ohio Oncology Center

Rex B Mowat
Ph: 800-444-3561

Rex B Mowat
Ph: 800-444-3561

Mayfield Heights

Hillcrest Cancer Center at Hillcrest Hospital

Anjali S Advani
Ph: 866-223-8100

Medina

Summa Health Center at Lake Medina

Jennifer E Payne
Ph: 330-375-6101

Mount Vernon

Knox Community Hospital

J. Philip Kuebler
Ph: 614-566-3275

Newark

Licking Memorial Cancer Care Program at Licking Memorial Hospital

J. Philip Kuebler
Ph: 614-566-3275

Oregon

St. Charles Mercy Hospital

Rex B Mowat
Ph: 800-444-3561

Portsmouth

Southern Ohio Medical Center Cancer Center

J. Philip Kuebler
Ph: 614-566-3275

Sandusky

North Coast Cancer Care, Incorporated

Anjali S Advani
Ph: 866-223-8100

Springfield

Community Hospital of Springfield and Clark County

J. Philip Kuebler
Ph: 614-566-3275

Strongsville

Cleveland Clinic Foundation - Strongsville

Anjali S Advani
Ph: 866-223-8100

Sylvania

Flower Hospital Cancer Center

Rex B Mowat
Ph: 800-444-3561

Toledo

CCOP - Toledo Community Hospital

Rex B Mowat
Ph: 800-444-3561

St. Anne Mercy Hospital

Rex B Mowat
Ph: 800-444-3561

Toledo Clinic, Incorporated - Main Clinic

Rex B Mowat
Ph: 800-444-3561

University of Toledo Medical Center

Rex B Mowat
Ph: 800-444-3561

Troy

UVMC Cancer Care Center at Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350

Warrensville Heights

South Pointe Hospital Cancer Care Center

Anjali S Advani
Ph: 866-223-8100

Westerville

Mount Carmel St. Ann's Cancer Center

J. Philip Kuebler
Ph: 614-566-3275

Wooster

Cleveland Clinic - Wooster

Anjali S Advani
Ph: 866-223-8100

Zanesville

Genesis - Good Samaritan Hospital

J. Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

Oklahoma
Oklahoma City

Stephenson Cancer Center at the University of Oklahoma

George B Selby
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

Oregon
Clackamas

Clackamas Radiation Oncology Center

Alison K Conlin
Ph: 503-215-6412

Gresham

Legacy Mount Hood Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Newberg

Providence Newberg Medical Center

Alison K Conlin
Ph: 503-215-6412

Oregon City

Willamette Falls Hospital

Alison K Conlin
Ph: 503-215-6412

Portland

Legacy Good Samaritan Hospital & Comprehensive Cancer Center

Jacqueline Vuky
Ph: 503-299-6500

Providence Cancer Center at Providence Portland Medical Center

Alison K Conlin
Ph: 503-215-6412

Providence St. Vincent Medical Center

Alison K Conlin
Ph: 503-215-6412

Tualatin

Legacy Meridian Park Hospital

Jacqueline Vuky
Ph: 503-299-6500

Pennsylvania
Danville

Geisinger Cancer Institute at Geisinger Health

Edward J Gorak
Ph: 570-271-5251

Hazleton

Geisinger Hazleton Cancer Center

Edward J Gorak
Ph: 570-271-5251

Lewisburg

Geisinger Medical Oncology at Evangelical Community Hospital

Edward J Gorak
Ph: 570-271-5251

Lewistown

Lewistown Hospital

Edward J Gorak
Ph: 570-271-5251

Phoenixville

Cancer Center at Phoenixville Hospital

Carl W. Sharer
Ph: 610-983-1908

Pottsville

Geisinger Medical Oncology-Pottsville

Edward J Gorak
Ph: 570-271-5251

State College

Geisinger Medical Group - Scenery Park

Edward J Gorak
Ph: 570-271-5251

Wilkes-Barre

Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center

Edward J Gorak
Ph: 570-271-5251

South Carolina
Charleston

Hollings Cancer Center at Medical University of South Carolina

Saurabh Chhabra
Ph: 843-792-9321

Florence

McLeod Regional Medical Center

Rajesh Bajaj
Ph: 843-679-7256

South Dakota
Rapid City

Rapid City Regional Hospital

Mark T Schroeder
Ph: 605-716-3982
Email: research@rcrh.org

Texas
Houston

Univeristy of Texas M.D. Anderson Cancer Center

Robert Zygmunt Orlowski
Ph: 713-792-3245

Virginia
Martinsville

Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County

Sreedhar Katragadda
Ph: 276-666-7827

Washington
Longview

Lower Columbia Regional Cancer Center at PeaceHealth-St. John Medical Center

Alison K Conlin
Ph: 503-215-6412

Vancouver

Legacy Salmon Creek Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Northwest Cancer Specialists at Vancouver Cancer Center

Alison K Conlin
Ph: 503-215-6412

Southwest Washington Medical Center Cancer Center

Alison K Conlin
Ph: 503-215-6412

Wisconsin
Burlington

Aurora Cancer Care-Burlington

Dhimant R. Patel
Ph: 800-252-2990

Chippewa Falls

Marshfield Clinic - Chippewa Center

Douglas J Reding
Ph: 715-389-4457

Eau Claire

Marshfield Clinic Cancer Care at Regional Cancer Center

Douglas J Reding
Ph: 715-389-4457

Elkhorn

Vince Lombardi Cancer Center at Aurora Lakeland Medical Center - Elkhorn

Dhimant R. Patel
Ph: 800-252-2990

Fond Du Lac

Aurora Health Center-Fond du Lac

Dhimant R. Patel
Ph: 800-252-2990

Grafton

Aurora Cancer Care-Grafton

Dhimant R. Patel
Ph: 800-252-2990

Green Bay

Green Bay Oncology, Limited at St. Mary's Hospital

Matthew L Ryan
Ph: 800-432-6049

Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center

Matthew L Ryan
Ph: 800-432-6049

St. Mary's Hospital Medical Center - Green Bay

Matthew L Ryan
Ph: 800-432-6049

St. Vincent Hospital Regional Cancer Center

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Green Bay at Aurora BayCare Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Kenosha

Oncology Alliance - Kenosha South

Dhimant R. Patel
Ph: 800-252-2990

La Crosse

Gundersen Lutheran Center for Cancer and Blood

Kurt Oettel
Ph: 608-775-2385
Email: cancerctr@gundluth.org

Madison

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center

Natalie S. Callander
Ph: 877-405-6866

Manitowoc

Holy Family Memorial Medical Center Cancer Care Center

Matthew L Ryan
Ph: 800-432-6049

Marinette

Bay Area Cancer Care Center at Bay Area Medical Center

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Marinette

Dhimant R. Patel
Ph: 800-252-2990

Marshfield

Marshfield Clinic - Marshfield Center

Douglas J Reding
Ph: 715-389-4457

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Dhimant R. Patel
Ph: 800-252-2990

Milwaukee

Aurora Cancer Care-Milwaukee

Dhimant R. Patel
Ph: 800-252-2990

Aurora Sinai Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Minocqua

Marshfield Clinic - Lakeland Center

Douglas J Reding
Ph: 715-389-4457

New Richmond

Cancer Center of Western Wisconsin

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Oconto Falls

Green Bay Oncology, Limited - Oconto Falls

Matthew L Ryan
Ph: 800-432-6049

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Dhimant R. Patel
Ph: 800-252-2990

Racine

Aurora Health Center - Racine

Dhimant R. Patel
Ph: 800-252-2990

Rhinelander

Ministry Medical Group at Saint Mary's Hospital

Douglas J Reding
Ph: 715-389-4457

Rice Lake

Marshfield Clinic - Indianhead Center

Douglas J Reding
Ph: 715-389-4457

Douglas J Reding
Ph: 715-389-4457

Sheboygan

Saint Nicholas Hospital

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Sheboygan

Dhimant R. Patel
Ph: 800-252-2990

Stevens Point

Marshfield Clinic at Saint Michael's Hospital

Douglas J Reding
Ph: 715-389-4457

Sturgeon Bay

Green Bay Oncology, Limited - Sturgeon Bay

Matthew L Ryan
Ph: 800-432-6049

Summit

Aurora Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Two Rivers

Vince Lombardi Cancer Clinic - Two Rivers

Dhimant R. Patel
Ph: 800-252-2990

Waukesha

Aurora Cancer Care-Waukesha

Dhimant R. Patel
Ph: 800-252-2990

Wausau

Marshfield Clinic - Wausau Center

Douglas J Reding
Ph: 715-389-4457

Wauwatosa

Oncology Alliance, SC - Milwaukee - West

Dhimant R. Patel
Ph: 800-252-2990

West Allis

Aurora Women's Pavilion of West Allis Memorial Hospital

Dhimant R. Patel
Ph: 800-252-2990

Weston

Diagnostic and Treatment Center

Douglas J Reding
Ph: 715-389-4457

Marshfield Clinic - Weston Center

Douglas J Reding
Ph: 715-389-4457

Wisconsin Rapids

Marshfield Clinic - Wisconsin Rapids Center

Douglas J Reding
Ph: 715-389-4457

Link to the current ClinicalTrials.gov record.
NLM Identifier NCT01668719
ClinicalTrials.gov processed this data on March 08, 2015

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.